Drug Discovery

#Antibody drug conjugate (ADC) #Big pharma #Drug development #Drug discovery #Heidelberg Pharma #Takeda #Therapeutic Antibodies

A global overview of therapeutic antibody development

DDW’s Megan Thomas takes a wide-angle look at the sector and speaks to experts and thought leaders about their predictions for therapeutic antibodies in 2025. Clinical advancements Marcelo Freire, Vice President of Global Medical Affairs, Therapeutic Area Head of Gastroenterology at Takeda, comments on monoclonal antibodies (mAbs) from a gastro… Read More

#Business & Investment #Exclusive Content

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data #Webinar

Webinar: Implement a successful data automation strategy

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#News

#Artificial intelligence (AI) #Drug discovery #Molecular research #Ozempic #Stanford University #Weight loss

AI-enabled molecule discovery rivals Ozempic in weight loss

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide — also known as Ozempic — in suppressing appetite and reducing body weight. Notably, testing in animals also showed that it worked without some of Ozempic’s side effects such as nausea, constipation and significant loss of muscle… Read More

#News

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Register now: Synthesised DNA for protein screening

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#2025 predictions #Drug development #Drug discovery #Regulatory

New modalities: Industry predictions for 2025

DDW’s Megan Thomas spoke with industry experts about their predictions for drug discovery opportunities in 2025. Previously, with a focus on technology, machine learning (ML) and artificial intelligence (AI), as well as neuroscience, cancer research, cell and gene therapy, diagnostics and regulation and drug policy. This is the final… Read More

#Exclusive Content #Regulatory #Trends & Analysis

#Business #Drug development #Drug discovery #Spinout #Start-ups #Turning Science into Business

New DDW Highlights podcast: 10 March 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are… Read More

#News

Red blood cells
#Assays #Cellular imaging #Drug discovery #High throughput screening #In vitro #Technical Note

Technical Note: Unlocking high-throughput potential

A new Technical Note from Lonza is now available entitled ‘Primary Human Umbilical Vein Endothelial Cells: A Qualitative, Real-time, In-vitro Tube Formation Assay‘. Download the Technical Note to learn more about these unique features: Co-culture model with high biological relevance Compatible with live-cell imaging which allows for real-time… Read More

#News

#Acute pancreatitis #Arrivo BioVentures #Drug discovery #Major depressive disorder #Meet the Researcher

Meet the researcher: Greg Rigdon, Arrivo BioVentures

DDW’s Megan Thomas looks at a day in the life of Greg Rigdon, Senior Vice President of Scientific Affairs at Arrivo BioVentures. MT: Can you tell us what you do and what you’re working on at the moment? GR: My Arrivo colleagues and I are working on two potentially breakthrough… Read More

#Exclusive Content

#Business #Drug development #Drug discovery #Spinout #Start-ups #Turning Science into Business

This week in drug discovery (3-7 March) 

News round-up for 3-7 March by DDW Senior Digital Content Editor Diana Spencer. Our news round-up this week focuses on start-ups, the innovative fledgling companies that are coming through and sparking new life into various areas of drug discovery. The top stories: Start-up… Read More

#News

Robot for drug discovery
#Artificial intelligence (AI) #Automation / robotics #Drug discovery #Insilico Medicine #Lab automation #Lab technology

First bipedal humanoid AI scientist joins drug discovery lab

Insilico Medicine has deployed the first bipedal humanoid in its AI-powered fully-robotic drug discovery laboratory.   The humanoid, called ‘Supervisor’, will be used for data acquisition and data generation for training of the embodied AI systems to learn the skills of human laboratory scientists.   The work… Read More

#News #Trending News

#Artificial intelligence (AI) #Data management #Drug development #Drug discovery #eBook

New eBook: Three ways to solve scientific FOMO

A new eBook is now available to download entitled ‘Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery‘, from CCC / RightsDirect. The authors explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies Utilising search alerts Effectively employing AI… Read More

#News

#Artificial intelligence (AI) #Data management #Drug development #Drug discovery

Unifying Data Sources: A Guide for Efficient, Comprehensive Research

In ‘Three Ways to Solve Scientific FOMO: Advice for Navigating Early Discovery’, we explore key functions that empower researchers to overcome the challenges of siloed data, including: Leveraging ontologies Utilising search alerts Effectively employing AI Read our ebook to learn how you can accelerate your breakthroughs in drug discovery. Read More

#Resources

#BioInnovation Institute #Biologics / Biotechnology #Biotech hubs #Drug discovery #Funding #Investment #Life sciences #Market reporting #Start-ups #United States

New podcast: Global epicentres of drug discovery innovation

This is the latest episode of the free DDW narrated podcast, titled “Where are the global epicentres of drug discovery innovation?”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the… Read More

#News

#Biologics #Cell line development #Cell lines #Drug discovery #Proteins

Where do we stand with cell line development?

DDW’s Megan Thomas examines the value and impact of cell line development in the drug discovery industry. When it comes to the creation of biologics, cell line development is an essential drug discovery process. From a functional perspective, when it comes to monoclonal antibodies (mAbs), enzymes, or other therapeutic proteins,… Read More

#Exclusive Content